SCHEMBL2807573

SCHEMBL2807573

COCCCn1nc(C=O)c2cc(F)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 4/20 0.41
AR P10275 1/20 0.40
KDM4C Q9H3R0 4/20 0.37
HSD17B10 Q99714 2/20 0.36
PTGER4 P35408 1/20 0.36
PER2 O15055 2/20 0.34
CRY1 Q16526 2/20 0.34
CRY2 Q49AN0 2/20 0.34
CNR1 P21554 1/20 0.34
ACHE P22303 1/20 0.34
CNR2 P34972 1/20 0.34
TNKS O95271 1/20 0.33
PARP1 P09874 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
TP53 P04637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GSK3B P49841 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810321 0.85 MAPK8 (0.42) KDM4EALDH1A1KDM4CHSD17B10PTGER4
SCHEMBL27774890 0.83 AR (0.43) KDM4EALDH1A1ARKDM4CHSD17B10
SCHEMBL19597374 0.82 ADORA2A (0.42) KDM4EALDH1A1ARKDM4CHSD17B10
SCHEMBL2809192 0.82 ALDH1A1 (0.46) KDM4EALDH1A1KDM4CHSD17B10PTGER4
SCHEMBL15791921 0.81 KDM4E (0.38) KDM4EALDH1A1ARKDM4CHSD17B10
SCHEMBL13131355 0.80 KDM4C (0.38) KDM4EALDH1A1KDM4CHSD17B10PER2
SCHEMBL2807452 0.80 KDM4C (0.38) KDM4EALDH1A1KDM4CHSD17B10PER2
SCHEMBL2806451 0.76 ELANE (0.45) KDM4EKDM4CHSD17B10TP53L3MBTL1
SCHEMBL15902179 0.75 ALDH1A1 (0.51) KDM4EALDH1A1ARKDM4CHSD17B10
SCHEMBL8241203 0.73 ALDH1A1 (0.58) KDM4EALDH1A1ACHEL3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975252-B2 Morpholine derivative SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2015-03-10 US disclosed
US-20100240644-A1 MORPHOLINE DERIVATIVE SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240644-A1 MORPHOLINE DERIVATIVE REN, AGTR1, AGTR2 KDM4E 689/4885ALDH1A1 2202/4885AR 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.